GLEEVEC vs PHYRAGO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. GLEEVEC and PHYRAGO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GLEEVEC	PHYRAGO
Rating	70/100	New
Pharmacy pays	~$25.80 /30	~$839.19 /30
Type	RX	RX
Active ingredient	IMATINIB MESYLATE	DASATINIB
Manufacturer	Novartis	Handa Therap
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome	Lymphoid Leukemia, Myeloid Leukemia

gleevec phyrago

Rating

70/100

New

Pharmacy pays

~$25.80 /30

~$839.19 /30

Type

Active ingredient

IMATINIB MESYLATE

DASATINIB

Manufacturer

Novartis

Handa Therap

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

Which is cheaper, Gleevec or Phyrago?

Gleevec costs pharmacies less to acquire — about $25.80 vs $839.19 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Gleevec and Phyrago?

Gleevec contains Imatinib Mesylate, while Phyrago contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.